187 related articles for article (PubMed ID: 30048609)
1. Helicobacter pylori eradication: influence of interleukin-1beta -31 C/T polymorphism.
Rech TF; Mazzoleni LE; Mazzoleni F; Francesconi CFM; Sander GB; Michita RT; Nabinger DD; Milbradt TC; Torresini RJS; Simon D
Braz J Infect Dis; 2018; 22(4):311-316. PubMed ID: 30048609
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Furuta T; Shirai N; Xiao F; El-Omar EM; Rabkin CS; Sugimura H; Ishizaki T; Ohashi K
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):22-30. PubMed ID: 15017629
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
[TBL] [Abstract][Full Text] [Related]
4. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
[TBL] [Abstract][Full Text] [Related]
6. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia.
Salem EM; Yar T; Bamosa AO; Al-Quorain A; Yasawy MI; Alsulaiman RM; Randhawa MA
Saudi J Gastroenterol; 2010; 16(3):207-14. PubMed ID: 20616418
[TBL] [Abstract][Full Text] [Related]
8. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
[TBL] [Abstract][Full Text] [Related]
9. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
10. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
Tan HJ; Rizal AM; Rosmadi MY; Goh KL
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
12. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
13. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
14. Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia.
Nabinger DD; Mazzoleni LE; Sander GB; Mazzoleni F; Osório MC; Klein MG; Rech TF; Basso da Silva L; de Moraes GS; Cristovam RA; Nardelli EF; Francesconi CF; Simon D
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706745
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
Schütze K; Hentschel E; Hirschl AM
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
17. Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients.
Tsukada K; Miyazaki T; Katoh H; Masuda N; Ojima H; Fukai Y; Nakajima M; Manda R; Fukuchi M; Kuwano H; Tsukada O
Scand J Gastroenterol; 2002 Nov; 37(11):1265-8. PubMed ID: 12465723
[TBL] [Abstract][Full Text] [Related]
18. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
Gisbert JP; Hermida C; Pajares JM
Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Influence of Interleukin-1β Gene Polymorphism on Gastric Inflammatory Response and Precancerous Lesions Development in Patients with Functional Dyspepsia.
Rech TF; Mazzoleni LE; Mazzoleni F; Francesconi CFM; Sander GB; Michita RT; Nabinger DD; de Bona LR; Milbradt TC; Ott EA; Breyer HP; Haas GM; Canevese AP; Stifft J; Simon D
Immunol Invest; 2020 Jul; 49(5):585-596. PubMed ID: 31909646
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
